Express Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Express pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Express Pharma Today - Breaking & Trending Today

Drug Makers Struggle to Replace Stimulants with Non-Addictive Alternatives

Drug Makers Struggle to Replace Stimulants with Non-Addictive Alternatives
hightimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hightimes.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Carl Hart , Lorraine Palmer , Richard Francis , Axsome Therapeutics Inc , Otsuka Pharmaceutical Co Ltd , Teva Pharmaceuticals , Neurocentria Incl Threonate Magnesium Salt , Columbia University , Express Pharma , Neurocentria Inc , L Threonate Magnesium , Pharma Analyst , Clinical Psychiatry ,

Who Owns Your Media: The Indian Express empire and where it stands today

Who Owns Your Media: The Indian Express empire and where it stands today ....

Nepal General , West Bengal , Uttar Pradesh , Andhra Pradesh , Madhya Pradesh , United States , Tamil Nadu , India General , Indira Gandhi , Deshbandhu Gupta , Munnaram Prasad , Nusli Wadia , Saroj Jain , Viveck Goenka , Ramnath Goenka , Vinayak Shete , Ritu Sarin , Varadarajulu Naidu , Dhirubhai Ambani , Alok Mehta , Loksatta Varsha Vedh , Manoj Sonthalia , Padma Shri , Lok Prabha , Padma Bhushan , Syama Prasad Mukherjee ,

FDA slaps import alert on India's Shilpa after sterile injectables issues multiply

Feb 19, 2021 9:41am
The FDA hit India s Shilpa with an import alert on all but three of its drugs after the company failed to address problems cited in an October warning letter. (Pixabay/qimono)
Just a few months after India-based drugmaker Shilpa Medicare found itself in the FDA s crosshairs, the company now faces a ban on the vast majority of its products in the U.S.
The FDA slapped an import alert on Shilpa Medicare s formulation plant in Telangana, India, according to a notice posted Thursday. The product ban comes on the heels of an FDA warning letter that cited the Indian drugmaker for multiple manufacturing violations. ....

Andhra Pradesh , Syneos Health , Rare Disease Innovations Institute , Telangana State Industrial Infrastructure Corporation , Shilpa Medicare , Express Pharma , Rare Disease , Making Progress , Gene Therapies , Webinar Series , Hindu Business , Fierce Pharma , Import Alert , Usfda Warning Letter , Drug Formulation , Drug Manufacturing , Manufacturing Plant , ஆந்திரா பிரதேஷ் , ரேர் நோய் புதுமைகள் நிறுவனம் , தெலுங்கானா நிலை தொழில்துறை உள்கட்டமைப்பு நிறுவனம் , ஷில்பா மருத்துவ , எக்ஸ்பிரஸ் பார்மா , ரேர் நோய் , தயாரித்தல் ப்ரோக்ரெஸ் , கீந் சிகிச்சைகள் , வெபினார் தொடர் ,